Eccrine hidrocystoma
☆ Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Li prezante tankou ti papul ble plen ak likid klè.
References
Eccrine hidrocystomas (EHs) se timè benign ki fòme nan kanal swe ekrin ki anfle. Yo souvan dire anpil tan epi yo ka vin pi mal pandan tan cho lè swe ogmante. EH anjeneral dyagnostike dapre sentòm yo, men yon byopsi po ka konfime li. Nou prezante de ka EH, ki konsantre sou karakteristik dèrmoskopik yo ak tretman siksè ak peptide toksin ki sanble ak toksin aktualite.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
○ Tretman
Refwadisman zòn ki afekte a ka diminye tanporèman gwosè zòn ki afekte a.
Tretman lazè se nòmalman efikas.